[3H] imipramine binding in brain samples from depressed suicides and controls: 5-HT uptake sites compared with sites defined by desmethylimipramine

Journal of Affective Disorders

Volumn 47, Issue 1-3, 1998, Pages 105-112

  Lawrence, Kevin M ^a   Kanagasundaram, Mohan ^a   Lowther, Sandra ^a   Katona, Cornelius L E ^b   Crompton, M Rufus ^a   Horton, Roger W ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Antidepressant drugs; Depression; Frontal cortex; Post mortem brain tissue; Putamen; Substantia nigra; Suicide; 3H imipramine binding sites

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BARBITURIC ACID; CLOMIPRAMINE; DESIPRAMINE; DEXTROPROPOXYPHENE; DIAZEPAM; DOSULEPIN; FLUPENTIXOL; HALOPERIDOL; IMIPRAMINE; LITHIUM; MIANSERIN; NITRAZEPAM; PARACETAMOL; PAROXETINE; PROCYCLIDINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SODIUM ION; TEMAZEPAM; THIORIDAZINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIFLUOPERAZINE; TRIMIPRAMINE; TRITIUM;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG BINDING SITE; DRUG OVERDOSE; FEMALE; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; ISOTOPE LABELING; MALE; MENTAL DISEASE; NEUROPHARMACOLOGY; PRIORITY JOURNAL; PUTAMEN; SEROTONINERGIC SYSTEM; SUBSTANTIA NIGRA; SUICIDE; ADOLESCENT; BINDING SITE; BRAIN; CHEMISTRY; FRONTAL LOBE; METABOLISM; MIDDLE AGED; RADIOASSAY; STATISTICS;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; BINDING SITES; BRAIN; CAUSE OF DEATH; DEPRESSIVE DISORDER; DESIPRAMINE; FEMALE; FRONTAL LOBE; HUMANS; IMIPRAMINE; MALE; MIDDLE AGED; PUTAMEN; RADIOLIGAND ASSAY; SEROTONIN; SUBSTANTIA NIGRA; SUICIDE; TRITIUM;

EID: 0031594661     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(97)00126-2     Document Type: Article

References (39)

1. Andersson, A., Eriksson, A., Marcusson, J., 1992. Unaltered number of brain serotonin uptake sites in suicide victims. J. Psychopharmacol. 6, 509-513.
2. Arango, V., Underwood, M.D., Gubbi, A.V., Mann, J.J., 1995. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res. 688, 121-133.
3. 3H-Imipramine binding in frontal cortex of suicides. Psychiatry Res. 30, 125-135.
4. 3H]imipramine binding of protein nature in the human brain: I. Characteristics. Brain Res. 425, 128-136.
5. Beskow, J., Gottfries, C.G., Roos, B.E., Winblad, B., 1976. Determination of monoamine and monoamine metabolites in the human brain: Post mortem studies in a group of suicides and in a control group. Acta. Psychiatr. Scand. 53, 7-20.
6. 3H]imipramine binding and serotonin uptake in rat cerebral cortex after prolonged treatment. Fundam. Clin. Pharmacol. 1, 327-333.
7. 2 receptor binding sites in depressed suicide victims. Brain Res. 443, 272-280.
8. Cheetham, S.C., Crompton, M.R., Czudek, C., Horton, R.W., Katona, C.L.E., Reynolds, G.P., 1989. Serotonin concentrations and turnover in brains of depressed suicides. Brain Res. 502, 332-340.
9. Crow, T.J., Cross, A.J., Cooper, S.J., Deakin, J.F.W., Ferrier, I.N., Johnson, J.A., Joseph, M.H., Owen, F., Poulter, M., Lofthouse, R., Corsellis, J.A.N., Chambers, D.R., Blessed, G., Perry, E.K., Perry, R.H., Tomlinson, B.E., 1984. Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicide victims. Neuropharmacology 23, 1561-1569.
10. 3H-paroxetine binding in depressed patients. Psychiatry Res. 26, 11-17.
11. 3H]paroxetine to platelets of depressed patients: Seasonal differences and effects of diagnostic classification. J. Affect. Disord. 32, 27-35.
12. Elliott, J.M., 1991. Peripheral markers in affective disorders. In: Horton, R.W., Katona, C.L.E. (Eds.), Biological Aspects of Affective Disorders. Academic Press, London, pp. 95-144.
13. Ferrier, I.N., McKeith, I.G., Cross, A.J., Perry, E.K., Candy, J.M., Perry, R.H., 1986. Postmortem neurochemical studies in depression. Ann. NY. Acad. Sci. 487, 128-142.
14. Gross-Isseroff, R., Israeli, M., Biegon, A., 1989. Autoradiographic analysis of tritiated imipramine binding in the human brain post mortem: Effects of suicide. Arch. Gen. Psychiatry 46, 237-241.
15. 3H]imipramine binding in rat brain. Eur. J. Pharmacol. 102, 481-488.
16. 3H]imipramine binding in rat hippocampus and its relationship to serotonin uptake. Can. J. Pharmacol. 65, 2422-2427.
17. 3H]imipramine binding in rat brain by serotonin and serotonin uptake inhibitors. Eur. J. Pharmacol. 148, 279-282.
18. 3H]imipramine binding in intact human platelets. Biol. Psychiatry 25, 576-584.
19. 2 receptors. J. Psychiatry Neurosci. 20, 11-19.
20. 2 sites in cortex and amygdala. Brain Res. 614, 37-44.
21. 3H]paroxetine binding on human platelets. Biol. Psychiatry 36, 281-291.
22. Johnson, A.M., 1991. The comparative pharmacological properties of selective serotonin re-uptake inhibitors in animals. In: Feighner, J.P., Boyer, W.F. (Eds.). Selective Serotonin Reuptake Inhibitors. John Wiley, Chichester, UK, pp. 37-70.
23. Laruelle, M., Abi-Dargham, A., Casanova, M.F., Toti, R., Weinberger, D.R., Kleinman, J.E., 1993. Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. Arch. Gen. Psychiatry 50, 810-818.
24. 3H]paroxetine binding, a marker of serotonin uptake sites. Biol. Psychiatry 24, 299-309.
25. 3H]paroxetine, in antidepressant-free depressed suicides. Brain Res. 526, 17-22.
26. 3H]paroxetine. Psychopharmacology 110, 235-239.
27. 3H] paroxetine, in controls and depressed patients before and after treatment with fluoxetine or lofepramine. Psychopharmacology 115, 261-264.
28. 3H]paroxetine in antidepressant drug-free depressed suicides and controls. J. Psychiatry Neurosci. 22, 185-191.
29. Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
30. 3H]imipramine to protease-sensitive and protease-resistant sites. J. Neurochem. 44, 705-711.
31. Meyerson, L.R., Wennogle, L.P., Abel, M.S., Coupet, J., Lippa, A.S., Rauh, C.E., Beer, B., 1982. Human brain receptor alterations in suicide victims. Pharmacol. Biochem. Behav. 17, 159-163.
32. 3H-paroxetine binding in control subjects and depressed patients: Relationship to serotonin uptake and age. Psychiatry Res. 51, 147-155.
33. Nelson, E.C., Sheline, Y.I., Bardgett, M.E., Jackson, J.L., Csernansky, J.G., 1995. Platelet paroxetine binding in major depressive disorder with and without comorbid obsessive-compulsive disorder. Psychiatry Res. 58, 117-125.
34. Owen, F., Chambers, D.R., Cooper, S.J., Crow, T.J., Johnson, J.A., Lofthouse, R., Poulter, M., 1986. Serotonergic mechanisms in brains of suicide victims. Brain Res. 362, 185-188.
35. Paul, S.M., Rehavi, M., Skolnick, P., Goodwin, F.K., 1984. High affinity binding of antidepressants to a biogenic amine transport site in human brain and platelets: Studies in depression. In: Post, R.M., Ballinger, J.C. (Eds.). Neurobiology of Mood Disorders. Williams and Wilkins, Baltimore, pp. 845-853.
36. Perry, E.K., Marshall, E.F., Blessed, G., Tomlinson, B.E., Perry, R.H., 1983. Decreased imipramine binding in the brains of patients with depressive illness. Br. J. Psychiatry 142, 188-192.
37. 3H]Imipramine high-affinity binding sites in rat brain. Effects of imipramine and lithium. Psychopharmacology 77, 94-97.
38. 3H-imipramine binding. Eur. J. Pharmacol. 61, 373-380.
39. Stanley, M., Virgilio, J., Gershon, S., 1982. Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science 216, 1337-1339.